View email in your browser. https://view.mail.23andme.com/?qs=4a180b984989fd28862dfff607b9b0f7ac1d0abd7bf912e1af7a33ad44f3482b137e7154d05021faf66bb1c503ea7f4139aae15914df8e2210619177f013f86980e6e465022b6b7dc5b8b71dd88fb7c0e877e907750c6d0a The Latest from 23andMe New reports. Fresh insights. New collaborations. It’s been an exciting couple of months at 23andMe. Read on to discover the latest updates, informative news and more from the exciting world of genetics. New Report: Type 2 Diabetes Nearly 40 percent of people in the United States are expected to develop type 2 diabetes in their lifetime.1 23andMe’s new Type 2 Diabetes report* explores the link between genetics and type 2 diabetes, and offers insights on how to reduce one’s chances of developing the disease. Developing the content for this report was a team effort. 23andMe scientists analyzed data from 2.5 million 23andMe customers who consented to participate in research to develop the model that assesses an individual’s genetic likelihood of developing type 2 diabetes. Learn more https://click.mail.23andme.com/?qs=95174a18a49015a91147ee7dd4cb814de54ed439263b9b43669186086c2fb0481676fefcd5440341b41474015a3f6b4b1e6660e65abc5f63 New Report: Familial Hypercholesterolemia In February, 23andMe released a new Genetic Health Risk report on familial hypercholesterolemia (FH).** FH is a genetic condition associated with very high levels of low-density lipoprotein (LDL), or “bad cholesterol”, which can increase the risk for early heart disease. About one in 250 people worldwide have FH, but the majority of people with the condition don’t know they have it.2 The report can be an important way for individuals to learn more about their risk for high LDL cholesterol levels related to FH and take steps to manage that risk. Learn more https://click.mail.23andme.com/?qs=95174a18a49015a9ff8035072cc7076f744082539090efe4e093b2067e4ed8f5670954198254bea61bcdc966adfddef8d66ccc598a5365f9 Announcement: FDA clears the way for new hereditary cancer report 23andMe’s quest to offer people direct access to important health information took another exciting step in January. The U.S. Food and Drug Administration cleared the way for us to provide a new Genetic Health Risk report on two of the most common variants influencing MUTYH-associated polyposis, a hereditary colorectal cancer syndrome. We are planning to release the report in the upcoming months to our Health + Ancestry customers who are on our latest genotyping platforms. Learn more https://click.mail.23andme.com/?qs=95174a18a49015a95e8fa71a1697c32e58c9a7781ca8e6d7ab8e5123bfdf26783694387da2b1890d73adc4590605963cdd5bf5e4ed381772 More regions. More reports. The most detailed view of your ancestry yet. When it comes to 23andMe’s Ancestry Service, the delight is in the details. The good news is our Ancestry Service just got a whole lot more detailed, thanks to the addition of more than 1,000 regions and 33 new population-specific pages called Ancestry Detail Reports. Learn more https://click.mail.23andme.com/?qs=95174a18a49015a9cc4aeab2abc70829516b24fc273ea3753ac73539817778a2c5debcd140465250947e86dd051f15ffb832a6c129f20f7a 23andMe and Lark Health: Turning genetic insights into healthy life choices Lark Health is a leader in chronic disease prevention and management using conversational A.I. technology. 23andMe is collaborating with Lark to give our Health + Ancestry Service customers an opportunity to access personalized digital coaching that integrates the results from some 23andMe genetic reports. For a monthly fee or it may be covered as a benefit with participating insurance, Lark provides two programs that can help Health + Ancestry customers make lifestyle changes that could be beneficial to their health. One that focuses on diabetes prevention and one that focuses on wellness coaching. Learn more https://click.mail.23andme.com/?qs=fabca2c11b56b2c5efe14c060494e56aae8ab9d182226373e0a46176b5e97c59a1929f5c9c92cbfefd3d2411c2f1901fe79da623f1961d85 Discover the healthy insight that resulted from Charlie’s DNA search Charlie was inspired to take the 23andMe test to gain insights into himself. What he discovered when he received his reports did more than change the way he viewed himself, it changed the way he lived his life -- for the better. Watch the video https://click.mail.23andme.com/?qs=fabca2c11b56b2c5ce5bbd1d421c7c89e41a843a588ad002c75c4efa9c18096f11f15292f134510bcdaf042a4a225bcfde0899960e9167eb Are you a risk taker? The answer may be partly in your DNA. A new study conducted by an international team of scientists, and incorporating data from 23andMe customers who consented to research, suggests that genetics may play a role in whether or not we engage in risky behavior such as smoking, drinking or even driving over the speed limit. It’s a whole new way to think about risk and our willingness to take it. Learn more https://click.mail.23andme.com/?qs=fabca2c11b56b2c59218591e413e8c996f5f2a24ff6d4e1fb1702f89c5e0c37b4564a594b780e9a8179de482d327108227222ae98d3fe030 ¹ https://click.mail.23andme.com/?qs=fabca2c11b56b2c5f9fc9f1288a51349de7c70b6d6e7b7d1ed602a83d6badd7c3ffdb8808ce1fd5436dd5e4e99e8e3ec6d0a55755e6da5fd ² https://click.mail.23andme.com/?qs=fabca2c11b56b2c5098bc09433104465ab0804c3291b67e99dbf7ba98c31d6d953a233c2e82e6a15df5db5724f0ccc12121d2ae239f7a435 *The 23andMe Type 2 Diabetes report is based on 23andMe research and incorporates more than 1,000 genetic variants to provide information on the likelihood of developing type 2 diabetes. The report does not account for lifestyle or family history and has not been reviewed by the US Food and Drug for additional important information. www.23andme.com/topics/health-predispositions/type-2-diabetes **The 23andMe PGS test health predisposition reports include both reports that meet US FDA requirements for genetic health risks and the 23andMe Type 2 Diabetes health predisposition report which is based on 23andMe research and has not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. The Familial Hypercholesterolemia genetic health risk report is indicated for reporting of one variant in the APOB gene and 23 variants in the LDLR gene and describes if a person has variants associated with an increased risk of developing very high LDL cholesterol, which can lead to heart disease. The majority of the variants included in this report have been most studied in people of European and Lebanese descent, as well as in the Old Order Amish. For important information and limitations regarding each genetic health risk report, click here 23andme.com/test-info/ You are receiving this email because you are a customer of 23andMe. (C) 2007-2019 23andMe, Inc. 23andMe, Inc 899 W. Evelyn Avenue Mountain View, CA 94041, USA update your 23andMe email preferences https://click.mail.23andme.com/?qs=fabca2c11b56b2c59a4cf7f40d8d29774de5c7a66cb7e8a4bd1de65d94d4a89d3350fd72fb02c4b68a5a0d742da26bcfe9c34770b7ad586f unsubscribe from 23andMe news and updates emails https://click.mail.23andme.com/unsub_center.aspx?qs=1890449f0bb25765a87d3bc0564352042b30e8ace1909e3ed6c4812a1b3bbc7b8ab8f2979d8619900972ae7138de31252c1a7b47ee8bb50d71d8bb84e375fdc5879001ee76040103707d444efd2cd86e